In a recent report, Savills analysts noted that Singapore’s overhang in supply arising from the 19,968 private residential ...
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a licensing agreement for its CHO Edge System with RevOpsis Therapeutics ("RevOpsis"), a nex ...
FDA Project Team supports the company’s proposed Phase 3 trial strategy, including overall trial design, target patient population, treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback